SequelSEC

Medicus Pharma Ltd. MDCX

Pharmaceutical Preparations · CIK 0001997296 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2026-06-30
Operating income
-$11.48M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Medicus Pharma Ltd. (MDCX) reported net income of -$11.62M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Medicus Pharma Ltd.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Medicus Pharma Ltd. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$11.48M-$8.60M-$7.79M-$15-$6.02M-$5.13M-$3.59M-$2.33M-$3.55M-$1.71M
Net income-$11.62M-$9.04M-$15.07M-$20.94M-$6.18M-$5.10M-$3.54M-$2.28M-$3.63M-$1.71M
Research & development$4.91M$2.70M$2.59M$1.68M$1.44M$2.01M$1.37M$564.14K$1.28M$321.38K
Weighted-average diluted sharesshares 55.06Mshares 29.54MUnavailableshares 18.63Mshares 14.28Mshares 12.24MUnavailableshares 9.51Mshares 8.17Mshares 8.08M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.21$-0.31Unavailable$-1.12$-0.43$-0.42Unavailable$-0.24$-0.44$-0.21
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$6.57M$5.89M$5.20M$5$4.58M$3.12M$2.22M$1.77M$2.28M$1.39M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Medicus Pharma Ltd. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$15.17M$6.37M$8.71M$8.66M$9.67M$3.98M$4.16MUnavailableUnavailableUnavailable
Total assets$27.12M$7.43M$10.06M$9.98M$11.93M$5.66M$5.65MUnavailableUnavailableUnavailable
Current assets$16.98M$7.28M$9.89M$9.78M$11.00M$5.09M$5.38MUnavailableUnavailableUnavailable
Total liabilities$28.84M$6.00M$10.02M$10.78M$8.69M$3.51M$2.51MUnavailableUnavailableUnavailable
Current liabilities$10.84M$5.95M$9.94M$10.66M$8.54M$3.34M$2.31MUnavailableUnavailableUnavailable
Total equity incl. NCI-$1.72M$1.43M$37.31K-$804.89K$3.25M$2.15M$3.13M$4.79M$7.07M-$559.96K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$6.73M$2.28M$3.44M$2.03M$1.77M$2.04M$1.28MUnavailableUnavailableUnavailable

Cash flow

Medicus Pharma Ltd. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$6.98M-$8.97M-$6.61M-$6.76M-$5.47M-$3.94M-$3.19M-$3.10M-$2.78M-$1.18M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailable$0UnavailableUnavailableUnavailable$0UnavailableUnavailableUnavailable
Financing cash flow$25.53M$6.83M$6.65M$10.37M$11.16M$3.76M$2.05M$0$10.64M$0
Net change in cash$18.83M-$2.34M$43.13K-$1.01M$5.69M-$181.89K-$1.14MUnavailableUnavailableUnavailable
Stock-based compensation$1.41M$599.31K$429.71K$852.76K$117.45K$112.28K$91.72K$0$585.44K$35.95K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Medicus Pharma Ltd. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio1.57x1.22x1.00x0.92x1.29x1.53x2.33xUnavailableUnavailableUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MDCX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-25View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-11View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.